India's Gennova Biopharma developing Omicron-specific Covid vaccine: Sources

Gennova Biopharmaceuticals, a Pune-based company which is making India's first mRNA vaccine, has submitted phase-2 trial data of its mRNA Covid-19 vaccine. The Drugs Controller General of India's (DCGI) Subject Expert Committee (SEC) will review the data soon.

Sources said the company has also developed an Omicron-specific vaccine, which will be tested on humans for efficacy & immunogenicity soon.

During his speech at the 76th United Nations General Assembly (UNGA), Prime Minister Narendra Modi had earlier stated that India’s first mRNA vaccine was in the final stages.